Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding

Charlotte Mérie; Lars Køber; Peter Skov Olsen; Charlotte Andersson; Gunnar Gislason; Jan Skov Jensen; Christian Torp-Pedersen

doi:10.1001/jama.2012.54506

Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding

Charlotte Mérie, Lars Køber, Peter Skov Olsen, Charlotte Andersson, Gunnar Gislason, Jan Skov Jensen, Christian Torp-Pedersen

Research output: Contribution to journal › Journal article › Research › peer-review

195 Citations (Scopus)

Abstract

The need for anticoagulation after surgical aortic valve replacement (AVR) with biological prostheses is not well examined.

Original language	English
Journal	J A M A: The Journal of the American Medical Association
Volume	308
Issue number	20
Pages (from-to)	2118-25
Number of pages	8
ISSN	0098-7484
DOIs	https://doi.org/10.1001/jama.2012.54506
Publication status	Published - 2012

Access to Document

10.1001/jama.2012.54506

Cite this

Mérie, C., Køber, L., Skov Olsen, P., Andersson, C., Gislason, G., Skov Jensen, J., & Torp-Pedersen, C. (2012). Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding. J A M A: The Journal of the American Medical Association, 308(20), 2118-25. https://doi.org/10.1001/jama.2012.54506

Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding. / Mérie, Charlotte; Køber, Lars; Skov Olsen, Peter; Andersson, Charlotte; Gislason, Gunnar; Skov Jensen, Jan; Torp-Pedersen, Christian.

In: J A M A: The Journal of the American Medical Association, Vol. 308, No. 20, 2012, p. 2118-25.

Research output: Contribution to journal › Journal article › Research › peer-review

Mérie, C, Køber, L, Skov Olsen, P, Andersson, C, Gislason, G, Skov Jensen, J & Torp-Pedersen, C 2012, 'Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding', J A M A: The Journal of the American Medical Association, vol. 308, no. 20, pp. 2118-25. https://doi.org/10.1001/jama.2012.54506

Mérie, Charlotte ; Køber, Lars ; Skov Olsen, Peter ; Andersson, Charlotte ; Gislason, Gunnar ; Skov Jensen, Jan ; Torp-Pedersen, Christian. / Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding. In: J A M A: The Journal of the American Medical Association. 2012 ; Vol. 308, No. 20. pp. 2118-25.

@article{5bd5a6836e7b4a71b70ea97f6ba71fe5,

title = "Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding",

abstract = "The need for anticoagulation after surgical aortic valve replacement (AVR) with biological prostheses is not well examined.",

author = "Charlotte M{\'e}rie and Lars K{\o}ber and {Skov Olsen}, Peter and Charlotte Andersson and Gunnar Gislason and {Skov Jensen}, Jan and Christian Torp-Pedersen",

year = "2012",

doi = "10.1001/jama.2012.54506",

language = "English",

volume = "308",

pages = "2118--25",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "20",

}

TY - JOUR

T1 - Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding

AU - Mérie, Charlotte

AU - Køber, Lars

AU - Skov Olsen, Peter

AU - Andersson, Charlotte

AU - Gislason, Gunnar

AU - Skov Jensen, Jan

AU - Torp-Pedersen, Christian

PY - 2012

Y1 - 2012

N2 - The need for anticoagulation after surgical aortic valve replacement (AVR) with biological prostheses is not well examined.

AB - The need for anticoagulation after surgical aortic valve replacement (AVR) with biological prostheses is not well examined.

U2 - 10.1001/jama.2012.54506

DO - 10.1001/jama.2012.54506

M3 - Journal article

C2 - 23188028

VL - 308

SP - 2118

EP - 2125

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0098-7484

IS - 20

ER -